Thermo Fisher Scientific Inc. (TMO) stock
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3034% above fair value
$700.22+0.78 (+0.11%)
Close on Nov 13, 2026Market cap $259.44BP/E 37.0Yield 0.25%
Thermo Fisher Scientific r&d expenses
Research and development expenses are spending on new products and technology.
Thermo Fisher Scientific's R&D Expenses for the twelve months ending Sep 26, 2026 was $1.40B, down 0.7% year over year. For fiscal 2025 it was $1.40B, up 0.5% from the year before. Over ten years it grew 7.3% a year on average. The highest annual figure on record is $1.47B in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.40B | +0.5% |
| FY2024 | Dec 31, 2024 | $1.39B | +4.0% |
| FY2023 | Dec 31, 2023 | $1.34B | -9.1% |
| FY2022 | Dec 31, 2022 | $1.47B | +4.6% |
| FY2021 | Dec 31, 2021 | $1.41B | +19.1% |
| FY2020 | Dec 31, 2020 | $1.18B | +17.7% |
| FY2019 | Dec 31, 2019 | $1.00B | +3.7% |
| FY2018 | Dec 31, 2018 | $967.00M | +9.0% |
| FY2017 | Dec 31, 2017 | $887.00M | +17.6% |
| FY2016 | Dec 31, 2016 | $754.00M | +9.0% |
| FY2015 | Dec 31, 2015 | $692.00M | +0.1% |
| FY2014 | Dec 31, 2014 | $691.10M | +74.7% |
| FY2013 | Dec 31, 2013 | $395.50M | +5.1% |
| FY2012 | Dec 31, 2012 | $376.40M | +10.6% |
| FY2011 | Dec 31, 2011 | $340.20M | +19.6% |
| FY2010 | Dec 31, 2010 | $284.40M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $348.00M | +0.6% |
| Q2 FY2026 | Jun 27, 2026 | $364.00M | +3.4% |
| Q1 FY2026 | Mar 28, 2026 | $336.00M | -1.8% |
| Q4 FY2025 | Dec 31, 2025 | $356.00M | -4.8% |
| Q3 FY2025 | Sep 27, 2025 | $346.00M | 0.0% |
| Q2 FY2025 | Jun 28, 2025 | $352.00M | +3.8% |
| Q1 FY2025 | Mar 29, 2025 | $342.00M | +3.3% |
| Q4 FY2024 | Dec 31, 2024 | $374.00M | +14.4% |
| Q3 FY2024 | Sep 28, 2024 | $346.00M | +8.5% |
| Q2 FY2024 | Jun 29, 2024 | $339.00M | -1.7% |
| Q1 FY2024 | Mar 30, 2024 | $331.00M | -4.3% |
| Q4 FY2023 | Dec 31, 2023 | $327.00M | -16.4% |
| Q3 FY2023 | Sep 30, 2023 | $319.00M | -9.1% |
| Q2 FY2023 | Jul 1, 2023 | $345.00M | -5.5% |
| Q1 FY2023 | Apr 1, 2023 | $346.00M | -4.9% |
| Q4 FY2022 | Dec 31, 2022 | $391.00M | -0.3% |
| Q3 FY2022 | Oct 1, 2022 | $351.00M | 0.0% |
| Q2 FY2022 | Jul 2, 2022 | $365.00M | +6.4% |
| Q1 FY2022 | Apr 2, 2022 | $364.00M | +13.7% |
| Q4 FY2021 | Dec 31, 2021 | $392.00M | +4.3% |
| Q3 FY2021 | Oct 2, 2021 | $351.00M | +18.6% |
| Q2 FY2021 | Jul 3, 2021 | $343.00M | +29.9% |
| Q1 FY2021 | Apr 3, 2021 | $320.00M | +30.6% |
| Q4 FY2020 | Dec 31, 2020 | $376.00M | +43.5% |
| Q3 FY2020 | Sep 26, 2020 | $296.00M | +19.8% |
| Q2 FY2020 | Jun 27, 2020 | $264.00M | +7.3% |
| Q1 FY2020 | Mar 28, 2020 | $245.00M | -1.2% |
| Q4 FY2019 | Dec 31, 2019 | $262.00M | +4.4% |
| Q3 FY2019 | Sep 28, 2019 | $247.00M | +2.9% |
| Q2 FY2019 | Jun 29, 2019 | $246.00M | +1.7% |
| Q1 FY2019 | Mar 30, 2019 | $248.00M | +6.0% |
| Q4 FY2018 | Dec 31, 2018 | $251.00M | +7.7% |
| Q3 FY2018 | Sep 29, 2018 | $240.00M | +10.6% |
| Q2 FY2018 | Jun 30, 2018 | $242.00M | +9.0% |
| Q1 FY2018 | Mar 31, 2018 | $234.00M | +8.8% |
| Q4 FY2017 | Dec 31, 2017 | $233.00M | +10.0% |
| Q3 FY2017 | Sep 30, 2017 | $217.00M | – |
| Q2 FY2017 | Jul 1, 2017 | $222.00M | – |
| Q1 FY2017 | Apr 1, 2017 | $215.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $211.80M | – |
See a number that looks wrong?